Enterin

Enterin is the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease

Industries

Biotechnology

Headquarters

Philadelphia, United States

Stage

Convertible Note

Employees

11-50

Links

Org chart

David Mccullough

CEO & Board Member

Collapse

Katherine Wolf

CFO

Denise Barbut

Co-Founder, Chief Medical Officer & Board Member

Michael Zasloff

Co-Founder, Chief Scientific Officer & Board Member

William Kinney

Co-Founder & SVP of R&D

Hilde Williams

Senior Regulatory Advisor, Regulatory Strategy & Operations

Christina Gallagher

Clinical Trials Logistics Manager

Constantine Ward

Global Head of Clinical Trial Supply

Denise Barbut MD FRCP

Co-Founder, President and CMO

D. Phillip Cox

VP Commercial Manufacturing

Felisha B.

Study start-up Lead/ QC reviewer (remote)

Jennifer Beezley

Associate Director, Clinical Trial Management

Kimberly Man, MBA, PMP

Vice President Operations

Teams

View all

Board of Directors

11 members

Leadership Team

2 members

CEO and Executive Team

2 members

Founding Team

1 members

Discover similar companies

Cytodyn

Vancouver, United States · Post IPO Equity

Regeneron

Tarrytown, United States · Post IPO Equity

Verve Therapeutics

Cambridge, United States · IPO

Biogen

Cambridge, United States

Pionyr Immunotherapeutics

South San Francisco, United States · Corporate Round

Helix

San Mateo, United States · Series C

Guardant Health

Redwood City, United States · Venture

miR Scientific

New York, United States

Genentech

South San Francisco, United States · Venture

Illumina

San Diego, United States

Scipher Medicine

Waltham, United States · Series D

Natera

Austin, United States · Post IPO Equity

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.